NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ACES Diagnostics

ACES Diagnostics

Private
Paradise Valley, ArizonaHealthcare & Life Scienceshttps://www.acesdiagnostics.com/

Last Round

Seed Round

Jun 25, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ACES Diagnostics, Inc. is a healthtech company that develops diagnostic testing technologies for the early detection of infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

Lyme disease diagnosticsLyme testAI diagnosticsearly Lyme detectionin vitro diagnosticsIVDmachine learning diagnosticstick-borne illness diagnosticsmultiplexed immunoassaydiagnostic biomarkersdiagnostic algorithmmedtechbiotechnologyprecision medicineLuminex immunoassay

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ACES Diagnostics Comps

Public and private peers based on sector, stage, and business model.

ACES Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ACES Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 25, 2026

Key People

Founding team and executive leadership

Tammy Crawford

Chief Executive Officer

Executive Team

Glenn de Souza

Chief Operating Officer

Executive Team

ACES Diagnostics Investors

Notable investors and investment history

ACES Diagnostics investors
InvestorRounds
Bay Area Lyme FoundationSeed Round
AZAdvancesSeed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    $400K raised in Seed Round.

  • Dec 23, 2025

    Grew 75% QoQ from 4 to 7 employees.

ACES Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ACES Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ACES Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersParadise Valley, Arizona
Employee Range9
Year Founded2017
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.